The role of lipid metabolism and creeping fat in disease assessment and prediction for Crohn’s disease - Scorecard - MDSpire

The role of lipid metabolism and creeping fat in disease assessment and prediction for Crohn’s disease

  • By

  • Ying Lei

  • Runjie Shi

  • Zihong Cai

  • Yiqing Li

  • Xiaowei Qiu

  • Xiang Li

  • Shanping Wang

  • Yan Sun

  • May 25, 2026

  • 0 min

Share

Clinical Scorecard: Lipid Metabolism and Creeping Fat: Their Impact on Evaluating and Predicting Crohn's Disease Outcomes

At a Glance

CategoryDetail
ConditionCrohn's Disease (CD)
Key MechanismsLipid metabolism disorders and creeping fat (CF) contribute to inflammation and disease progression.
Target PopulationPatients with Crohn's Disease, including those with extraintestinal manifestations.
Care SettingClinical settings involving gastrointestinal assessment and management.

Key Highlights

  • CD is characterized by transmural inflammation and can lead to significant disability.
  • Creeping fat (CF) is a pathological feature in CD that influences inflammation and fibrosis.
  • Dyslipidemia is associated with systemic inflammation and may reflect disease activity.
  • Current assessment methods include endoscopy, imaging, and clinical symptom evaluation.
  • Long-term prognosis for CD patients shows a high incidence of disability.

Guideline-Based Recommendations

Diagnosis

  • Utilize endoscopic findings and clinical symptom assessment for diagnosis.

Management

  • Implement a comprehensive assessment combining objective methods to guide treatment decisions.

Monitoring & Follow-up

  • Conduct repeated endoscopy to assess active inflammation and treatment response.

Risks

  • Endoscopy may carry risks such as complications and procedural difficulties.

Patient & Prescribing Data

Individuals diagnosed with Crohn's Disease, including those experiencing complications.

Monitoring lipid levels and CF may provide insights into disease activity and prognosis.

Clinical Best Practices

  • Employ a combination of endoscopic, imaging, and biomarker assessments for accurate disease evaluation.
  • Recognize the limitations of clinical symptoms in reflecting intestinal inflammation.

Related Resources & Content

Original Source(s)

Related Content